CN107006840A - A kind of Saussurea involucrata culture capsule and preparation method thereof - Google Patents
A kind of Saussurea involucrata culture capsule and preparation method thereof Download PDFInfo
- Publication number
- CN107006840A CN107006840A CN201710099251.3A CN201710099251A CN107006840A CN 107006840 A CN107006840 A CN 107006840A CN 201710099251 A CN201710099251 A CN 201710099251A CN 107006840 A CN107006840 A CN 107006840A
- Authority
- CN
- China
- Prior art keywords
- saussurea involucrata
- involucrata culture
- powder
- capsule
- fine powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001145025 Saussurea involucrata Species 0.000 title claims abstract description 70
- 239000002775 capsule Substances 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 69
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 28
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 27
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims abstract description 27
- 241000222336 Ganoderma Species 0.000 claims abstract description 26
- 239000002994 raw material Substances 0.000 claims abstract description 25
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 16
- 230000036039 immunity Effects 0.000 claims abstract description 7
- 238000012856 packing Methods 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 13
- 239000011122 softwood Substances 0.000 claims description 12
- 239000011812 mixed powder Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000007689 inspection Methods 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 235000020985 whole grains Nutrition 0.000 claims description 6
- 235000013305 food Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 230000003749 cleanliness Effects 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 238000005469 granulation Methods 0.000 claims description 3
- 230000003179 granulation Effects 0.000 claims description 3
- 239000007887 hard shell capsule Substances 0.000 claims description 3
- 235000020344 instant tea Nutrition 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000005022 packaging material Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000007901 soft capsule Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 229920001542 oligosaccharide Polymers 0.000 claims 1
- 150000002482 oligosaccharides Chemical class 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000011669 selenium Substances 0.000 description 18
- 230000000694 effects Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000005186 women's health Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12G—WINE; PREPARATION THEREOF; ALCOHOLIC BEVERAGES; PREPARATION OF ALCOHOLIC BEVERAGES NOT PROVIDED FOR IN SUBCLASSES C12C OR C12H
- C12G3/00—Preparation of other alcoholic beverages
- C12G3/04—Preparation of other alcoholic beverages by mixing, e.g. for preparation of liqueurs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a kind of Saussurea involucrata culture capsule and preparation method thereof, it is characterised in that the Saussurea involucrata culture capsule is made up of the raw material of following weight percents：Saussurea involucrata culture 4 8%, ganoderma spove powder 40 60%, fruiting bodies of cordyceps militaris 10 28%, chitosan oligosaccharide 5 20%, Se-enriched yeast 1 5%.Combination of the invention by finding such a new resources, applied to raising immunity, prevention disease, health care, the purpose treated.
Description
Technical field
The invention discloses a kind of Saussurea involucrata culture capsule and preparation method thereof.
Background technology
With the development of World Economics and science and technology, the whole world progresses into aging society, and the increase of elderly population makes
Various infirmitiess of age are obtained increasingly to increase.The menopausal syndrome as caused by Woman climacteric and its complication, such as osteoporosis
It is increasingly becoming the serious disease of harm middle aged and aged women health.In addition, majority's hypoimmunity, easy various diseases.
There is the Saussurea involucrata culture capsule of given efficacy in the presence of some in the prior art, but it is not immune individually for improving
This effect of power and the capsule researched and developed, also not by Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide
This several is respectively provided with of 5-20%, Se-enriched yeast improves the capsule that the medicine of immunity is combined.
The present invention is by finding the combinations of such a new resources, applied to improving immunity, prevention disease, health care, control
The purpose for the treatment of.
Saussurea involucrata culture has effects that regulation immunity, anti-oxidant, antibacterial, Adjust-blood lipid, increase bone density, and above-mentioned work(
Effect has experimental data and research contents to prove.
Chitosan oligosaccharide have anti-hypertension, preventing arteriosclerosis, anti-oxidant, mithridatism, regulation cholesterol, improve liver function, change
Effect of kind sexual function, improvement gut function.Above-mentioned effect also has foundation.
Ganoderma lucidum is mild-natured Chinese medicine, and medicine-food two-purpose is immunoregulatory effect.Ganoderma lucidum enters the heart, liver, spleen, stomach, kidney five
Through there is strong kidney to act on.Lucidum spore powder is also the same.Saussurea involucrata (Saussureainvolucrate (Kar.et Kir.)
Sch.Bip) it is the distinctive rare Chinese herbal medicine in Xinjiang.Uygur medicine thinks that saussurea involucrata invigorating kidney, promoting blood circulation, strengthening the bones and muscles, trophic nerve is adjusted
Abnormal humour.The traditional Chinese medical science thinks that saussurea involucrata warming kidney and enhancing yang, expelling wind and eliminating dampness restores menstrual flow and invigorates blood circulation.The unique effects of saussurea involucrata are increasingly by weight
Depending on, clinic be mainly used in innate deficiency of YANG in the body, the prevention of disease such as rheumatism numbness pain, underbelly pain, irregular menstruation of blood stasis resistance network and
Treatment, also in terms of Robust speaker feature.To protect the species that this is rare, using the plant cell engineering with China's independent intellectual property rights
Technology prepares saussurea involucrata substitute and succeeded.
Show through system research, Saussurea involucrata culture not only contain the active component close with natural snow lotus, and also have with
Suitable many pharmacological activity.Its main pharmacological analgesia, anti-inflammatory, antirheumatic；Suppress platelet aggregation, drop blood
Fat, improvement blood circulation；
There is adjustment effect to immune system；Also anti-oxidant, radioresistance and many pharmacodynamics such as antifatigue simultaneously
Effect.
The content of the invention
A kind of Saussurea involucrata culture capsule, it is characterised in that food compositions are made up of the raw material of following weight percents：Snow
Lotus culture 4-8%, ganoderma spove powder 40-60%, fruiting bodies of cordyceps militaris 10-28%, chitosan oligosaccharide 5-20%, Se-enriched yeast
1-5%.
Further, the formulation of the food compositions be tablet, it is hard shell capsules, soft capsule, solid beverage, assembled alcoholic drinks, instant
Tea, oral liquid.
Further, for improving immunity.
Further, the Saussurea involucrata culture capsule is made up of the raw material of following weight percents：Saussurea involucrata culture 4.5%,
Ganoderma spove powder 51%, fruiting bodies of cordyceps militaris 25%, chitosan oligosaccharide 18%, Se-enriched yeast 1.5%.
Further, the Saussurea involucrata culture capsule is made up of the raw material of following weight percents：It is Saussurea involucrata culture 4%, broken
Wall lucidum spore powder 55%, fruiting bodies of cordyceps militaris 22%, chitosan oligosaccharide 15%, Se-enriched yeast 4%.
Further, the Saussurea involucrata culture capsule is made up of the raw material of following weight percents：It is Saussurea involucrata culture 8%, broken
Wall lucidum spore powder 49%, fruiting bodies of cordyceps militaris 20%, chitosan oligosaccharide 20%, Se-enriched yeast 3%.
Further, the Saussurea involucrata culture capsule is made up of the raw material of following weight percents：Saussurea involucrata culture 5.5%,
Ganoderma spove powder 47.5%, fruiting bodies of cordyceps militaris 27%, chitosan oligosaccharide 17.5%, Se-enriched yeast 2.5%.
Further, a kind of preparation method of Saussurea involucrata culture capsule, it is characterised in that：The preparation method is by following steps
It is made：(1) Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide, Se-enriched yeast are chosen；Each raw material removes
After outer packing, inner packing enters clean area by logistics corridor；
(2) crush, sieve：By Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide, Se-enriched yeast
It is each to cross the fine powder that 80 mesh sieves obtain each raw material；
(3) weigh：Saussurea involucrata culture fine powder, ganoderma spove powder fine powder, fruiting bodies of cordyceps militaris are weighed by formula rate
Fine powder, chitosan oligosaccharide fine powder, Se-enriched yeast fine powder；
(4) mix：First the fine powder of Saussurea involucrata culture is mixed five minutes with the fine powder of Se-enriched yeast, mixed powder is obtained；Will be mixed
Close powder to mix 25 minutes with ganoderma spove powder fine powder, fruiting bodies of cordyceps militaris fine powder, chitosan oligosaccharide fine powder, obtain and always mix
Powder；
(5) softwood processed：Purified water is added into softwood processed in total mixed powder, softwood is obtained；
(6) pelletize：Softwood is crossed into the granulation of 40 mesh sieves, wet granular is obtained；
(7) dry, whole grain：Wet granular is placed in 45-60 DEG C of drying, until moisture≤6%, after 40 mesh sieve whole grains,
Obtain dry particl；
(8) filling capsule：Filling capsule is carried out, capsule (400mg/) is obtained；
(9) polish：Remove the powder of capsule surface；
(10) select：Select the underproof product of removing；
(11) inner packing：60/bottle, packaging material meets YBB00122002 oral stable medicinal polythene bottle with high density
Standard；
(12) outer packing：Housing material meets the rule of GB/T6543 single and double corrugated boxes for transport packages
It is fixed；
(13) quality inspection：Product inspection is carried out by Quality Inspector；
(14) be put in storage：It can be put in storage after the assay was approved；
Further, the preparation process is main is prepared in the clean sanitary district of production environment, and outer packing is removed from raw material
Prepared into clean area to inner packing process in the clean sanitary district of production environment, workshop cleanliness factor is 300,000
Level.
Brief description of the drawings
The present invention is further described with reference to the accompanying drawings and examples.
Fig. 1 is a kind of preparation method Structure and Process schematic diagram of Saussurea involucrata culture capsule.
Embodiment
Shown example is further described to patent of the present invention below in conjunction with the accompanying drawings
Embodiment 1：
A kind of Saussurea involucrata culture capsule, it is characterised in that the Saussurea involucrata culture capsule by following weight percents raw material system
Into：Saussurea involucrata culture 4.5%, ganoderma spove powder 51%, fruiting bodies of cordyceps militaris 25%, chitosan oligosaccharide 18%, Se-enriched yeast
1.5%.
Embodiment 2：
A kind of Saussurea involucrata culture capsule, it is characterised in that the Saussurea involucrata culture capsule by following weight percents raw material system
Into：Saussurea involucrata culture 4%, ganoderma spove powder 55%, fruiting bodies of cordyceps militaris 22%, chitosan oligosaccharide 15%, Se-enriched yeast 4%.
Embodiment 3：
A kind of Saussurea involucrata culture capsule, it is characterised in that the Saussurea involucrata culture capsule by following weight percents raw material system
Into：Saussurea involucrata culture 8%, ganoderma spove powder 49%, fruiting bodies of cordyceps militaris 20%, chitosan oligosaccharide 20%, Se-enriched yeast 3%.
Embodiment 4：
A kind of Saussurea involucrata culture capsule, it is characterised in that the Saussurea involucrata culture capsule by following weight percents raw material system
Into：Saussurea involucrata culture 5.5%, ganoderma spove powder 47.5%, fruiting bodies of cordyceps militaris 27%, chitosan oligosaccharide 17.5%, selenium-rich ferment
Mother 2.5%.
Further, the formulation of the food compositions of formula rate is tablet, hard shell capsules, soft capsule, solid drink in the above 4
Material, assembled alcoholic drinks, instant tea, oral liquid.
Further, this Saussurea involucrata culture capsule is used to improve immunity.
Further, the preparation method of the Saussurea involucrata culture capsule of several formulas of the above, comprises the following steps：
(1) Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide, Se-enriched yeast are chosen；Each raw material
Remove after outer packing, inner packing enters clean area by logistics corridor；
(2) crush, sieve：By Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide, Se-enriched yeast
It is each to cross the fine powder that 80 mesh sieves obtain each raw material；
(3) weigh：Saussurea involucrata culture fine powder, ganoderma spove powder fine powder, fruiting bodies of cordyceps militaris are weighed by formula rate
Fine powder, chitosan oligosaccharide fine powder, Se-enriched yeast fine powder；
(4) mix：First the fine powder of Saussurea involucrata culture is mixed five minutes with the fine powder of Se-enriched yeast, mixed powder is obtained；Will be mixed
Close powder to mix 25 minutes with ganoderma spove powder fine powder, fruiting bodies of cordyceps militaris fine powder, chitosan oligosaccharide fine powder, obtain and always mix
Powder；
(5) softwood processed：Purified water is added into softwood processed in total mixed powder, softwood is obtained；
(6) pelletize：Softwood is crossed into the granulation of 40 mesh sieves, wet granular is obtained；
(7) dry, whole grain：Wet granular is placed in 45-60 DEG C of drying, until moisture≤6%, after 40 mesh sieve whole grains,
Obtain dry particl；
(8) filling capsule：Filling capsule is carried out, capsule (400mg/) is obtained；
(9) polish：Remove the powder of capsule surface；
(10) select：Select the underproof product of removing；
(11) inner packing：60/bottle, packaging material meets YBB00122002 oral stable medicinal polythene bottle with high density
Standard；
(12) outer packing：Housing material meets the rule of GB/T6543 single and double corrugated boxes for transport packages
It is fixed；
(13) quality inspection：Product inspection is carried out by Quality Inspector；
(14) be put in storage：It can be put in storage after the assay was approved；
(15) the clean sanitary district of production environment：Outer packing is removed from raw material and enters clean area to inner packing process, produces car
Between cleanliness factor be 300,000 grades.
Further, the preparation process is main is prepared in the clean sanitary district of production environment, and outer packing is removed from raw material
Prepared into clean area to inner packing process in the clean sanitary district of production environment, workshop cleanliness factor is 300,000
Level.
The purpose of above-described embodiment is design and the feature for illustrating patent of the present invention, is professional can understand
The content of patent of the present invention is simultaneously implemented according to this, the protection domain without limiting patent of the present invention.It is all according to patent table of the present invention
The equivalence changes that essence is done are stated, should be all included within the protection domain of patent of the present invention.
Claims (9)
1. a kind of Saussurea involucrata culture capsule, it is characterised in that food compositions are made up of the raw material of following weight percents：Saussurea involucrata
Culture 4-8%, ganoderma spove powder 40-60%, fruiting bodies of cordyceps militaris 10-28%, chitosan oligosaccharide 5-20%, Se-enriched yeast 1-
5%.
2. a kind of Saussurea involucrata culture capsule according to claim 1, it is characterised in that the formulation of the food compositions is piece
Agent, hard shell capsules, soft capsule, solid beverage, assembled alcoholic drinks, instant tea, oral liquid.
3. a kind of Saussurea involucrata culture capsule according to claim 1, it is characterised in that for improving immunity.
4. a kind of Saussurea involucrata culture capsule according to claim 1, it is characterised in that the Saussurea involucrata culture capsule is by following
The raw material of percentage by weight is made：Saussurea involucrata culture 4.5%, ganoderma spove powder 51%, fruiting bodies of cordyceps militaris 25%, shell are few
Sugar 18%, Se-enriched yeast 1.5%.
5. a kind of Saussurea involucrata culture capsule according to claim 1, it is characterised in that the Saussurea involucrata culture capsule is by following
The raw material of percentage by weight is made：Saussurea involucrata culture 4%, ganoderma spove powder 55%, fruiting bodies of cordyceps militaris 22%, chitosan oligosaccharide
15%th, Se-enriched yeast 4%.
6. a kind of Saussurea involucrata culture capsule according to claim 1, it is characterised in that the Saussurea involucrata culture capsule is by following
The raw material of percentage by weight is made：Saussurea involucrata culture 8%, ganoderma spove powder 49%, fruiting bodies of cordyceps militaris 20%, chitosan oligosaccharide
20%th, Se-enriched yeast 3%.
7. a kind of Saussurea involucrata culture capsule according to claim 1, it is characterised in that the Saussurea involucrata culture capsule is by following
The raw material of percentage by weight is made：Saussurea involucrata culture 5.5%, ganoderma spove powder 47.5%, fruiting bodies of cordyceps militaris 27%, shell
Oligosaccharides 17.5%, Se-enriched yeast 2.5%.
8. a kind of preparation method of Saussurea involucrata culture capsule according to claim 1-7, it is characterised in that：The preparation method
It is made up of following steps：(1) Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide, Se-enriched yeast are chosen；
Each raw material removes after outer packing, and inner packing enters clean area by logistics corridor；
(2) crush, sieve：By Saussurea involucrata culture, ganoderma spove powder, fruiting bodies of cordyceps militaris, chitosan oligosaccharide, each mistake of Se-enriched yeast
80 mesh sieves obtain the fine powder of each raw material；
(3) weigh：By formula rate weigh Saussurea involucrata culture fine powder, ganoderma spove powder fine powder, fruiting bodies of cordyceps militaris fine powder,
Chitosan oligosaccharide fine powder, Se-enriched yeast fine powder；
(4) mix：First the fine powder of Saussurea involucrata culture is mixed five minutes with the fine powder of Se-enriched yeast, mixed powder is obtained；By mixed powder
Mixed 25 minutes with ganoderma spove powder fine powder, fruiting bodies of cordyceps militaris fine powder, chitosan oligosaccharide fine powder, obtain total mixed powder；
(5) softwood processed：Purified water is added into softwood processed in total mixed powder, softwood is obtained；
(6) pelletize：Softwood is crossed into the granulation of 40 mesh sieves, wet granular is obtained；
(7) dry, whole grain：Wet granular is placed in 45-60 DEG C of drying, until moisture≤6%, after 40 mesh sieve whole grains, obtains dry
Particle；
(8) filling capsule：Filling capsule is carried out, capsule (400mg/) is obtained；
(9) polish：Remove the powder of capsule surface；
(10) select：Select the underproof product of removing；
(11) inner packing：60/bottle, packaging material meets YBB00122002 oral stable medicinal polythene bottle with high density standards；
(12) outer packing：Housing material meets the regulation of GB/T6543 single and double corrugated boxes for transport packages；
(13) quality inspection：Product inspection is carried out by Quality Inspector；
(14) be put in storage：It can be put in storage after the assay was approved.
9. a kind of preparation method of Saussurea involucrata culture capsule according to claim 8, it is characterised in that：Preparation process master
To be prepared in the clean sanitary district of production environment, removing outer packing from raw material enters clean area to inner packing process in production
Prepared by environment cleaning sanitary district, workshop cleanliness factor is 300,000 grades.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710099251.3A CN107006840A (en) | 2017-02-23 | 2017-02-23 | A kind of Saussurea involucrata culture capsule and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710099251.3A CN107006840A (en) | 2017-02-23 | 2017-02-23 | A kind of Saussurea involucrata culture capsule and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107006840A true CN107006840A (en) | 2017-08-04 |
Family
ID=59440101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710099251.3A Pending CN107006840A (en) | 2017-02-23 | 2017-02-23 | A kind of Saussurea involucrata culture capsule and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107006840A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107961252A (en) * | 2017-12-08 | 2018-04-27 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of ganoderma spove powder capsule |
| CN108056353A (en) * | 2017-12-07 | 2018-05-22 | 青岛明药堂医疗股份有限公司 | A kind of isotonic solid beverage and its preparation, application method containing chitin derivativ |
| CN108464500A (en) * | 2018-03-13 | 2018-08-31 | 武春风 | A kind of dietary composition of auxiliary adjustment hypertension |
| CN108671002A (en) * | 2018-05-31 | 2018-10-19 | 南京中生生物科技有限公司 | A kind of composition of the extract containing Saussurea involucrata culture and its application |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1463744A (en) * | 2002-06-07 | 2003-12-31 | 中国科学院大连化学物理研究所 | A health food possessing immunity regulating function and method for preparing the same |
| CN1931197A (en) * | 2006-09-11 | 2007-03-21 | 张连龙 | Health product and medicine containing glossy ganoderma and selenium |
| US20130028968A1 (en) * | 2011-07-29 | 2013-01-31 | Andy Teh-An Huang | Compositions and methods to relieve chronic diseases symptoms |
| CN103238841A (en) * | 2013-05-23 | 2013-08-14 | 昆明宝特药用植物研究开发有限公司 | Food composition containing Maca and saussurea involucrata culture and application thereof |
| CN103859406A (en) * | 2014-03-19 | 2014-06-18 | 济南利民制药有限责任公司 | Immunity-improving colla corii asini and jujube capsule |
| CN106361781A (en) * | 2016-10-28 | 2017-02-01 | 芜湖市诺康生物科技有限公司 | Composition for enhancing immunity and preparation method of composition |
-
2017
- 2017-02-23 CN CN201710099251.3A patent/CN107006840A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1463744A (en) * | 2002-06-07 | 2003-12-31 | 中国科学院大连化学物理研究所 | A health food possessing immunity regulating function and method for preparing the same |
| CN1931197A (en) * | 2006-09-11 | 2007-03-21 | 张连龙 | Health product and medicine containing glossy ganoderma and selenium |
| US20130028968A1 (en) * | 2011-07-29 | 2013-01-31 | Andy Teh-An Huang | Compositions and methods to relieve chronic diseases symptoms |
| CN103238841A (en) * | 2013-05-23 | 2013-08-14 | 昆明宝特药用植物研究开发有限公司 | Food composition containing Maca and saussurea involucrata culture and application thereof |
| CN103859406A (en) * | 2014-03-19 | 2014-06-18 | 济南利民制药有限责任公司 | Immunity-improving colla corii asini and jujube capsule |
| CN106361781A (en) * | 2016-10-28 | 2017-02-01 | 芜湖市诺康生物科技有限公司 | Composition for enhancing immunity and preparation method of composition |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108056353A (en) * | 2017-12-07 | 2018-05-22 | 青岛明药堂医疗股份有限公司 | A kind of isotonic solid beverage and its preparation, application method containing chitin derivativ |
| CN107961252A (en) * | 2017-12-08 | 2018-04-27 | 芜湖市诺康生物科技有限公司 | A kind of preparation method of ganoderma spove powder capsule |
| CN108464500A (en) * | 2018-03-13 | 2018-08-31 | 武春风 | A kind of dietary composition of auxiliary adjustment hypertension |
| CN108671002A (en) * | 2018-05-31 | 2018-10-19 | 南京中生生物科技有限公司 | A kind of composition of the extract containing Saussurea involucrata culture and its application |
| CN108671002B (en) * | 2018-05-31 | 2021-06-01 | 南京中生生物科技有限公司 | Composition containing saussurea involucrate culture extract and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107006840A (en) | A kind of Saussurea involucrata culture capsule and preparation method thereof | |
| CN101999573B (en) | Method for preparing composite bee pollen health-care product | |
| CN101524375B (en) | Wet-process wall breaking method of lucidum spore powder | |
| CN104274509B (en) | Healthy product composition containing cordyceps sinensis and eucommia Bark male flower and its preparation method and application | |
| CN104306617A (en) | Maca and Acai-containing composition as well as preparation method and application thereof | |
| CN103621981A (en) | Edible fungus freeze-drying superfine powder as well as preparation method and application thereof | |
| CN106343126A (en) | Preparation method of peony and lucid ganoderma chocolates | |
| CN102204617B (en) | Mulberry powder health care tea and preparation method thereof | |
| CN101966205B (en) | Auxiliary material-free superfine powder tablets and preparation method thereof | |
| CN104705630A (en) | Manufacturing method of pleurotus eryngii crystalline grains | |
| CN103830280B (en) | Preparation method of spirulina extract | |
| CN105851245A (en) | Novel cream preservative | |
| CN106417817A (en) | Tea bag with effects of helping sleep and soothing nerves and preparation method thereof | |
| CN102872181A (en) | Preparation method of gout treating medicine oral liquid | |
| KR101881663B1 (en) | Earthworm fermented extracts and method for manuracturing thereof and natural cosmetics and functional health food comprising same | |
| CN104082747A (en) | Health food with function of improving body immunity and preparation method of health food | |
| CN108925992A (en) | Protect liver supports lung, health food of runchang detoxification and preparation method thereof | |
| CN106035850A (en) | Poria cocos-trichosahthes kirilowii maxin health tea and preparation process thereof | |
| CN105101817A (en) | Edible composition, preparation method therefor, and food product comprising the composition | |
| KR101490710B1 (en) | Cosmetics composition comprising donkey milk and method of fabricating thereof | |
| CN103027957B (en) | Cistanche cell disruption method and buccal tablet prepared by cistanche micropowder obtained by method | |
| CN105941731A (en) | Tricholoma matsutake tea, preparation method and application thereof | |
| CN106107374A (en) | A kind of spirulina health-care beverage and preparation method thereof | |
| CN102948555A (en) | Healthy tea for helping digestion and lubricating intestines | |
| CN109620774A (en) | A kind of herbal mixture care toothpaste and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170804 |
|
| RJ01 | Rejection of invention patent application after publication |